533 related articles for article (PubMed ID: 28120717)
1. Understanding Epigenetic Alterations in Alzheimer's and Parkinson's Disease: Towards Targeted Biomarkers and Therapies.
Ciceri F; Rotllant D; Maes T
Curr Pharm Des; 2017; 23(5):839-857. PubMed ID: 28120717
[TBL] [Abstract][Full Text] [Related]
2. Epigenetics in Parkinson's and Alzheimer's diseases.
Marques S; Outeiro TF
Subcell Biochem; 2013; 61():507-25. PubMed ID: 23150265
[TBL] [Abstract][Full Text] [Related]
3. Neurodegeneration and epigenetics: A review.
Ghosh P; Saadat A
Neurologia (Engl Ed); 2023; 38(6):e62-e68. PubMed ID: 37344098
[TBL] [Abstract][Full Text] [Related]
4. DNA methylation in neurodegenerative disorders: a missing link between genome and environment?
Iraola-Guzmán S; Estivill X; Rabionet R
Clin Genet; 2011 Jul; 80(1):1-14. PubMed ID: 21542837
[TBL] [Abstract][Full Text] [Related]
5. Pharmacoepigenomic Interventions as Novel Potential Treatments for Alzheimer's and Parkinson's Diseases.
Teijido O; Cacabelos R
Int J Mol Sci; 2018 Oct; 19(10):. PubMed ID: 30332838
[TBL] [Abstract][Full Text] [Related]
6. Role of epigenetics in Alzheimer's and Parkinson's disease.
Kwok JB
Epigenomics; 2010 Oct; 2(5):671-82. PubMed ID: 22122050
[TBL] [Abstract][Full Text] [Related]
7. Epigenetic mechanisms in Parkinson's disease.
Feng Y; Jankovic J; Wu YC
J Neurol Sci; 2015 Feb; 349(1-2):3-9. PubMed ID: 25553963
[TBL] [Abstract][Full Text] [Related]
8. Epigenetics and the neurodegenerative process.
Słowikowski B; Owecki W; Jeske J; Jezierski M; Draguła M; Goutor U; Jagodziński PP; Kozubski W; Dorszewska J
Epigenomics; 2024 Apr; 16(7):473-491. PubMed ID: 38511224
[TBL] [Abstract][Full Text] [Related]
9. Targeting epigenetic modifications in Parkinson's disease therapy.
Zhang D; Zhang J; Wang Y; Wang G; Tang P; Liu Y; Zhang Y; Ouyang L
Med Res Rev; 2023 Sep; 43(5):1748-1777. PubMed ID: 37119043
[TBL] [Abstract][Full Text] [Related]
10. The roles of epigenetic modifications in neurodegenerative diseases.
Qu W; Zhuang Y; Li X
Zhejiang Da Xue Xue Bao Yi Xue Ban; 2021 Oct; 50(5):642-650. PubMed ID: 34986527
[TBL] [Abstract][Full Text] [Related]
11. Novel Approaches for the Treatment of Alzheimer's and Parkinson's Disease.
Van Bulck M; Sierra-Magro A; Alarcon-Gil J; Perez-Castillo A; Morales-Garcia JA
Int J Mol Sci; 2019 Feb; 20(3):. PubMed ID: 30743990
[TBL] [Abstract][Full Text] [Related]
12. Epigenetics in Alzheimer's Disease: Perspective of DNA Methylation.
Qazi TJ; Quan Z; Mir A; Qing H
Mol Neurobiol; 2018 Feb; 55(2):1026-1044. PubMed ID: 28092081
[TBL] [Abstract][Full Text] [Related]
13. An Overview of Epigenetic Changes in the Parkinson's Disease Brain.
Klokkaris A; Migdalska-Richards A
Int J Mol Sci; 2024 Jun; 25(11):. PubMed ID: 38892355
[TBL] [Abstract][Full Text] [Related]
14. Role of epigenetics in Alzheimer's disease pathogenesis.
Stoccoro A; Coppedè F
Neurodegener Dis Manag; 2018 Jun; 8(3):181-193. PubMed ID: 29888987
[TBL] [Abstract][Full Text] [Related]
15. DNA methylation in Parkinson's disease.
Wüllner U; Kaut O; deBoni L; Piston D; Schmitt I
J Neurochem; 2016 Oct; 139 Suppl 1():108-120. PubMed ID: 27120258
[TBL] [Abstract][Full Text] [Related]
16. Epigenetic mechanisms in Alzheimer's disease: implications for pathogenesis and therapy.
Wang J; Yu JT; Tan MS; Jiang T; Tan L
Ageing Res Rev; 2013 Sep; 12(4):1024-41. PubMed ID: 23688931
[TBL] [Abstract][Full Text] [Related]
17. Epigenetics of neurological diseases.
Shanker OR; Kumar S; Dixit AB; Banerjee J; Tripathi M; Sarat Chandra P
Prog Mol Biol Transl Sci; 2023; 198():165-184. PubMed ID: 37225320
[TBL] [Abstract][Full Text] [Related]
18. Cell-replacement and gene-therapy strategies for Parkinson's and Alzheimer's disease.
Korecka JA; Verhaagen J; Hol EM
Regen Med; 2007 Jul; 2(4):425-46. PubMed ID: 17635050
[TBL] [Abstract][Full Text] [Related]
19. Epigenetic targeting of histone deacetylase: therapeutic potential in Parkinson's disease?
Harrison IF; Dexter DT
Pharmacol Ther; 2013 Oct; 140(1):34-52. PubMed ID: 23711791
[TBL] [Abstract][Full Text] [Related]
20. Iron neurochemistry in Alzheimer's disease and Parkinson's disease: targets for therapeutics.
Belaidi AA; Bush AI
J Neurochem; 2016 Oct; 139 Suppl 1():179-197. PubMed ID: 26545340
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
